HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $115,000 | -34.3% | 23,200 | 0.0% | 0.00% | – |
Q4 2021 | $175,000 | -15.0% | 23,200 | -11.1% | 0.00% | – |
Q3 2021 | $206,000 | -43.1% | 26,100 | 0.0% | 0.00% | – |
Q2 2021 | $362,000 | +13.1% | 26,100 | +70.6% | 0.00% | – |
Q1 2021 | $320,000 | +7.0% | 15,300 | -15.0% | 0.00% | – |
Q4 2020 | $299,000 | -2.3% | 18,000 | 0.0% | 0.00% | – |
Q3 2020 | $306,000 | +10.9% | 18,000 | +8.4% | 0.00% | – |
Q2 2020 | $276,000 | – | 16,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |